Organogenesis Holdings (ORGO) Other Non-Current Liabilities (2017 - 2025)
Organogenesis Holdings has reported Other Non-Current Liabilities over the past 9 years, most recently at $1.2 million for Q4 2025.
- Quarterly results put Other Non-Current Liabilities at $1.2 million for Q4 2025, up 33.45% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (up 33.45% YoY), and the annual figure for FY2025 was $1.2 million, up 33.45%.
- Other Non-Current Liabilities for Q4 2025 was $1.2 million at Organogenesis Holdings, down from $2.5 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for ORGO hit a ceiling of $3.7 million in Q1 2021 and a floor of $894000.0 in Q4 2024.
- Median Other Non-Current Liabilities over the past 5 years was $1.2 million (2023), compared with a mean of $1.5 million.
- Biggest five-year swings in Other Non-Current Liabilities: crashed 88.78% in 2021 and later soared 138.33% in 2025.
- Organogenesis Holdings' Other Non-Current Liabilities stood at $1.6 million in 2021, then decreased by 27.94% to $1.1 million in 2022, then rose by 8.11% to $1.2 million in 2023, then decreased by 26.3% to $894000.0 in 2024, then surged by 33.45% to $1.2 million in 2025.
- The last three reported values for Other Non-Current Liabilities were $1.2 million (Q4 2025), $2.5 million (Q3 2025), and $3.0 million (Q2 2025) per Business Quant data.